EXPRESSION LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 IN RADICAL NEPHRECTOMY SPECIMENS AS A PROGNOSTIC PREDICTOR IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUNITINIB

被引：0
|
作者：
Terakawa, Tomoaki
Miyake, Hideaki
Kusuda, Yuji
Fujisawa, Masato
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.1819
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1788
引用
收藏
页码：E721 / E722
页数：2
相关论文
共 50 条
  • [31] Vascular endothelial growth factor expression is increased in renal cell carcinoma
    Nicol, D
    Hii, SI
    Walsh, M
    Teh, B
    Thompson, L
    Kennett, C
    Gotley, D
    JOURNAL OF UROLOGY, 1997, 157 (04): : 1482 - 1486
  • [32] Soluble Vascular Endothelial Growth Factor Receptor-2 as a Predictor of Cardiovascular Events in Patients With Chronic Heart Failure
    Iguchi, Moritake
    Wada, Hiromichi
    Akao, Masaharu
    Ura, Shuichi
    Masunaga, Nobutoyo
    Ishii, Mitsuru
    Unoki, Takashi
    Abe, Mitsuru
    Takabayashi, Kensuke
    Yamashita, Yugo
    Hamatani, Yasuhiro
    Ogawa, Hisashi
    Satoh-Asahara, Noriko
    Shimatsu, Akira
    Hasegawa, Koji
    CIRCULATION, 2013, 128 (22)
  • [33] The Expression Level of Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor Receptor-3, and Insulin-Like Growth Factor II mRNA Binding Protein 3 in Renal Cell Carcinoma: Can these Markers Indicate Poor Prognosis in Immunohistochemical Examination?
    Eronat, Omer
    Kandemir, Olcay
    Onursever, Aykut
    CLINICAL CANCER INVESTIGATION JOURNAL, 2018, 7 (01): : 14 - 22
  • [34] Altered Expression of Endogenous Soluble Vascular Endothelial Growth Factor Receptor-2 Is Involved in the Progression of Esophageal Squamous Cell Carcinoma
    Wu, Zhi-Yong
    Chen, Tao
    Zhao, Qing
    Huang, Jian-Hao
    Chen, Jie-Xin
    Zheng, Chun-Peng
    Xu, Xiu-E
    Wu, Jian-Yi
    Xu, Li-Yan
    Li, En-Min
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2013, 61 (05) : 340 - 347
  • [35] Vascular endothelial growth factor (VEGF) expression is a prognostic factor in renal cell carcinomas
    Paradis, V
    Eschwège, P
    Blanchet, P
    Ba, N
    Benoit, G
    Jardin, A
    Bedossa, P
    LABORATORY INVESTIGATION, 1999, 79 (01) : 103A - 103A
  • [36] Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
    Fukuda, Hironori
    Takagi, Toshio
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Shimizu, Satoru
    Nagashima, Yoji
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 539 - 546
  • [37] Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
    Hironori Fukuda
    Toshio Takagi
    Tsunenori Kondo
    Kazuhiko Yoshida
    Satoru Shimizu
    Yoji Nagashima
    Kazunari Tanabe
    International Journal of Clinical Oncology, 2018, 23 : 539 - 546
  • [38] PROGNOSTIC VALUE OF THE GLASGOW PROGNOSTIC SCORE FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH CYTOREDUCTIVE NEPHRECTOMY
    Fukuda, Hironori
    Takagi, Toshio
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Shimizu, Satoru
    Nagashima, Yoji
    Tanabe, Kazunari
    JOURNAL OF UROLOGY, 2018, 199 (04): : E490 - E490
  • [39] Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial
    Ma, Jianhui
    Song, Yan
    Shou, Jianzhong
    Bai, Yuxian
    Li, Hanzhong
    Xie, Xiaodong
    Luo, Hong
    Ren, Xiubao
    Liu, Jiyan
    Ye, Dingwei
    Bai, Xianzhong
    Fu, Cheng
    Qin, Shukui
    Wang, Jinwan
    Zhou, Ai-Ping
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [40] Contrasting Prognostic Implications of Platelet-Derived Growth Factor Receptor-β and Vascular Endothelial Growth Factor Receptor-2 in Patients with Angiosarcoma
    Yonemori, Kan
    Tsuta, Koji
    Ando, Masashi
    Hirakawa, Akihiro
    Hatanaka, Yutaka
    Matsuno, Yoshihiro
    Chuman, Hirokazu
    Yamazaki, Naoya
    Fujiwara, Yasuhiro
    Hasegawa, Tadashi
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (10) : 2841 - 2850
12345